社保基金二季度调仓动向曝光，近50只重仓股年内平均涨幅超20%
Di Yi Cai Jing·2025-08-14 13:10

Core Insights - The Social Security Fund has significantly increased its holdings in over 50 listed companies, with a total shareholding exceeding 800 million shares and a market value surpassing 15.1 billion yuan [1][5] - More than 60% of the companies in which the fund has invested reported a year-on-year increase in net profit for the first half of the year [6] Group 1: Investment Strategy - In the second quarter, the Social Security Fund entered 17 new stocks and increased holdings in 15 stocks, while reducing holdings in 9 stocks [1] - The new investments span various sectors, including basic chemicals, home appliances, social services, computers, and transportation, indicating a diversified investment approach [4][3] - The fund's preference is for stocks with stable and growing performance, particularly in the banking, chemical, and electronics sectors [3] Group 2: Performance Metrics - The average increase in stock prices for the fund's holdings since the beginning of the year is over 22%, with more than 70% of the stocks experiencing price increases [2][5] - Notable performers include Guomai Culture with a cumulative increase of over 140%, and Dingtong Technology with an increase exceeding 133% [5] - In the second quarter alone, the average increase for the fund's holdings was 0.51%, with 11 out of the 17 new stocks showing price increases [5] Group 3: Financial Performance - Over 70% of the companies in which the Social Security Fund is invested reported a year-on-year increase in net profit for the first half of the year, with some companies like Rongzhi Rixin showing a staggering increase of 2063.42% [6][7] - However, some companies in the fund's portfolio, particularly in the basic chemicals and building materials sectors, experienced significant declines in net profit [7] - The fund's adjustments reflect a keen focus on the performance of individual stocks, with notable reductions in holdings for companies like Huajing Co. and Aidesheng Biology, which saw declines in net profit [4][7]